BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8245658)

  • 1. [Visceral fat obesity].
    Tarui S
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1547-53. PubMed ID: 8245658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Over-weight as risk factor with special regard to hypertension, arteriosclerosis and gout].
    Schollmeyer P
    Z Allgemeinmed; 1972 Oct; 48(29):1342-5. PubMed ID: 4636977
    [No Abstract]   [Full Text] [Related]  

  • 3. [Life style-related disease].
    Matsuzawa Y
    Nihon Rinsho; 2001 Jan; 59(1):188-94. PubMed ID: 11197854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral fat].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():699-705. PubMed ID: 12355836
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cutoff point of visceral fat area as a goal for improving risk factors of arteriosclerosis in patients with glucose intolerance].
    Nagano M; Sasaki H; Kumagai S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():417-20. PubMed ID: 15779415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adipose tissue distribution in children with excessive body weight and the possibility of development of complications of obesity. II. Positive family history in relation to arteriosclerosis risk factor and the constitutional type of obesity in children].
    Krawczuk-Rybakowa M; Pedziński W; Urban M; Siwiński J
    Pediatr Pol; 1989 Jul; 64(7):467-73. PubMed ID: 2640698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regional differences in fat metabolism--diabetogenic and atherogenic obesity].
    Vague J; Vague P; Jubelin J; Barre A
    Harefuah; 1989 Dec; 117(12):437-41. PubMed ID: 2695425
    [No Abstract]   [Full Text] [Related]  

  • 8. [The exact location of diabetogenic and atherogenic fat].
    Vague J
    An R Acad Nac Med (Madr); 1990; Spec No():43-51. PubMed ID: 2270857
    [No Abstract]   [Full Text] [Related]  

  • 9. Upper body fat predominance: an endocrine and metabolic chaos.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1991; 53(4):283-303. PubMed ID: 1950150
    [No Abstract]   [Full Text] [Related]  

  • 10. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
    Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
    Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin resistance syndrome, visceral fat syndrome].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():792-8. PubMed ID: 9434566
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, carbohydrate, and lipid interactions in the elderly.
    Bierman EL
    Curr Concepts Nutr; 1976; 4():171-6. PubMed ID: 770088
    [No Abstract]   [Full Text] [Related]  

  • 14. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary report on electronic measurement of volume distribution curves of isolated human fatty cells in obesity and their relations to diabetes mellitus].
    Hammermüller B; Leonhardt W; Hanefeld M
    Dtsch Gesundheitsw; 1970 Oct; 25(43):2020-2. PubMed ID: 5487499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperuricemia as a unique marker for metabolic syndrome].
    Nakajima H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():269-73. PubMed ID: 15779385
    [No Abstract]   [Full Text] [Related]  

  • 17. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic complications of visceral obesity: contribution to the aetiology of type 2 diabetes and implications for prevention and treatment.
    Lemieux S; Després JP
    Diabete Metab; 1994; 20(4):375-93. PubMed ID: 7843469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
    Nakamura T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study in vitro of lipolysis in the adipose tissue of subjects with diabetes mellitus].
    Giovannelli G; De Luca FM; Gragnoli G
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(2):919-31. PubMed ID: 6001561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.